Limited-efficacy Testing of SDS and NEMOST for Early Onset Neuromuscular Scoliosis (BiPOWR)
Limited-efficacy Testing of Spring Distraction System (SDS) and a Bilateral One Way Rod (NEMOST) for Early Onset Neuromuscular Scoliosis (BiPOWR)
Sponsor: EUROS
Listed as NCT04021784, this NA trial focuses on Distraction System and Growth Friendly System and remains completed. Sponsored by EUROS, it has been updated 9 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jul 2023 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2022 — Jul 2023 [monthly]
Recruiting NA
-
Jan 2022 — Jun 2022 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Jun 2021 — Jan 2022 [monthly]
Recruiting NA
-
Jan 2021 — Jun 2021 [monthly]
Recruiting NA
-
Nov 2019 — Jan 2021 [monthly]
Recruiting NA
-
Aug 2019 — Nov 2019 [monthly]
Recruiting NA
First recorded
May 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- EUROS
- UMC Utrecht
For direct contact, visit the study record on ClinicalTrials.gov .